Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NVAX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVAXNovavax$6.37-9.0%$8.13$3.81▼$23.86$1.03B2.928.02 million shs2.92 million shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVAXNovavax0.00%-7.89%-15.97%-11.73%+46.44%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNVAXNovavax3.9688 of 5 stars3.22.00.04.72.81.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVAXNovavax 2.43Hold$18.00182.49% UpsideCurrent Analyst Ratings BreakdownLatest NVAX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/28/2025NVAXNovavaxBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$19.002/27/2025NVAXNovavaxTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 3/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVAXNovavax$682.16M1.50N/AN/A($6.04) per share-1.05Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVAXNovavax-$545.06M-$1.33N/A79.652.85-32.18%N/A-17.05%5/9/2025 (Estimated)Latest NVAX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/27/2025Q4 24NVAXNovavax-$0.75-$0.51+$0.24-$0.51$85.48 million$88.31 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNVAXNovavaxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVAXNovavaxN/A0.930.93Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVAXNovavax53.04%Insider OwnershipCompanyInsider OwnershipNVAXNovavax1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVAXNovavax1,990160.84 million158.58 millionOptionableNVAX HeadlinesRecent News About These CompaniesModerna, Novavax Shares Are Tumbling Monday: What's Going On?March 31 at 10:42 AM | benzinga.comVaccine stocks fall after key FDA official resigns in protest of RFK Jr.March 31 at 10:13 AM | cnbc.comNovavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on ItMarch 31 at 10:05 AM | zacks.comBiotech stocks tumble on reports FDA's top vaccine regulator to leaveMarch 31 at 7:25 AM | reuters.comNovavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy NowMarch 30 at 6:15 PM | insidermonkey.comNovavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy NowMarch 30 at 6:15 PM | finance.yahoo.comSwiss National Bank Boosts Stake in Novavax, Inc. (NASDAQ:NVAX)March 28 at 3:30 AM | marketbeat.comWhy Novavax (NVAX) Dipped More Than Broader Market TodayMarch 27, 2025 | zacks.comModerna, Novavax Shares Are Sliding Wednesday: What's Going On?March 26, 2025 | benzinga.comModerna, Novavax, and Pfizer shares fall amid U.S. vaccine fund cutsMarch 26, 2025 | za.investing.comU.S. reportedly eyeing funding cuts to Gavi, the global vaccine allianceMarch 26, 2025 | msn.comZacks Research Estimates Novavax FY2027 EarningsMarch 25, 2025 | americanbankingnews.comZacks Research Comments on Novavax FY2027 EarningsMarch 24, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Increases Holdings in Novavax, Inc. (NASDAQ:NVAX)March 22, 2025 | marketbeat.comNovavax (NVAX) Stock Dips While Market Gains: Key FactsMarch 19, 2025 | zacks.comNovavax (NASDAQ:NVAX) Stock Price Down 6.1% - Here's WhyMarch 19, 2025 | marketbeat.comInvestors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to KnowMarch 17, 2025 | zacks.com2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth BuyingMarch 15, 2025 | fool.comMonaco Asset Management SAM Has $2.29 Million Stake in Novavax, Inc. (NASDAQ:NVAX)March 15, 2025 | marketbeat.comNovavax Appoints Margaret McGlynn To Succeed James Young As Chair Of The BoardMarch 13, 2025 | nasdaq.comUnusually active option classes on open March 13thMarch 13, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNVAX Company DescriptionsNovavax NASDAQ:NVAX$6.37 -0.63 (-8.97%) As of 02:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/24 - 03/28 JPMorgan: The 'NVIDIA of Banking' Poised for More Gains? Lululemon Pulls Back Into Classic Dip-Buying Opportunity Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low Netflix Poised for Significant Rally as a Safe Haven Stock Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback Joby Aviation Stock: Analyst Confidence and Smart Money Align Get Paid With Paychex: Dividends and Higher Prices Too Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
